CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.

ABSTRACT: BACKGROUND: Evidence indicates that CYP1A1 MspI polymorphism might be a possible risk factor for several malignancies. A growing body of literature has been devoted to the association of CYP1A1 MspI polymorphism with acute myeloid leukemia (AML). However, the results remain conflicting. The aim of the present study was to derive a more precise estimation of the relationship. METHODS: Meta-analyses assessing the association of CYP1A1 MspI variation with AML were conducted and subgroup analyses on ethnicity and age groups were further performed. Eligible studies were identified for the period up to May 2012. RESULTS: A total of ten case-control studies including 1330 cases and 3688 controls were selected for analysis. The overall data failed to indicate a significant association of CYP1A1 MspI polymorphism with AML risk (C vs T: OR?=?1.13; 95%CI?=?0.87-1.48; CC vs TT: OR?=?1.72; 95%CI?=?0.99-3.01; CC?+?TC vs TT: OR?=?1.16; 95%CI?=?0.86-1.55). In subgroup analysis stratified by ethnicity, significant AML risk was shown among Asians (CC?+?TC vs TT: OR?=?1.33; 95%CI?=?1.09-1.62) but not Caucasians or mixed races. In subgroup analysis regarding age groups, no associations were observed in either the childhood AML or the adult AML subgroups. CONCLUSION: The results of the present study suggested that CYP1A1 MspI polymorphism might be a risk factor for AML among Asians. Further investigations are needed to confirm the conclusions.

SUBMITTER: Zhuo W 

PROVIDER: S-EPMC3444413 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature